Showing results (71-80 of 107) with videos related to

Sort By:
Pageof 11
Therapeutic Advances in Medical Oncology|April 12, 2018
Estrogenicity of essential oils is not required to relieve symptoms of urogenital atrophy in breast cancer survivorsBruno M Simões, Bertram Kohler, Robert B Clarke, et al.
Cancer Prevention Research (Philadelphia, Pa.)|August 7, 2009
Biomarkers of dietary energy restriction in women at increased risk of breast cancerKai Ren Ong, Andrew H Sims, Michelle Harvie, et al.
Breast Cancer Research : BCR|December 1, 2019
Development of clinically relevant in vivo metastasis models using human bone discs and breast cancer patient-derived xenograftsDiane Lefley, Faith Howard, Fawaz Arshad, et al.
Cellular Oncology (Dordrecht, Netherlands)|October 21, 2024
SUMOylation regulates the aggressiveness of breast cancer-associated fibroblastsAngelica Martínez-López, Guiomar Infante, Marina Mendiburu-Eliçabe, et al.
Cancer Letters|May 24, 2019
PAK4 regulates stemness and progression in endocrine resistant ER-positive metastatic breast cancerAngélica Santiago-Gómez, Thomas Kedward, Bruno M Simões, et al.
Breast Cancer Research : BCR|December 4, 2014
Risk determination and prevention of breast cancerAnthony Howell, Annie S Anderson, Robert B Clarke, et al.
Oncotarget|February 21, 2014
P-cadherin signals through the laminin receptor α6β4 integrin to induce stem cell and invasive properties in basal-like breast cancer cellsAndré Filipe Vieira, Ana Sofia Ribeiro, Maria Rita Dionísio, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2024
Tumor circadian clock strength influences metastatic potential and predicts patient prognosis in luminal A breast cancerShi-Yang Li, Jan A Hammarlund, Gang Wu, et al.
Stem Cells (Dayton, Ohio)|March 6, 2012
P-cadherin is coexpressed with CD44 and CD49f and mediates stem cell properties in basal-like breast cancerAndré Filipe Vieira, Sara Ricardo, Matthew Paul Ablett, et al.
BMC Cancer|April 13, 2019
FKBPL and its peptide derivatives inhibit endocrine therapy resistant cancer stem cells and breast cancer metastasis by downregulating DLL4 and Notch4Lana McClements, Stephanie Annett, Anita Yakkundi, et al.
Pageof 11